DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

48.85 -0.68 (-1.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $48.85 -1.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.81
Previous Close $49.53
Daily Range $48.51 - $49.39
52-Week Range $45.69 - $61.70
Market Cap $136.5B
P/E Ratio 13.80
Dividend (Yield) $1.84 (3.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,086,713
Average Daily Volume 13,127,556
Current FY EPS $3.57




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy in a Market Crash

Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.

Ligand (LGND) Beats on Q4 Earnings, Raises 2016 Outlook

Following Alpha: Franchise Partners - Q4 2015 Review

Notable ETF Inflow Detected - IVE, BAC, MRK, UTX

Dow Movers: DIS, V

Short Sellers Increase Bets in Major Pharma

ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet

Pfizer Gets Back to Growth

Guidance for 2016 suggests that a corner is turning for this industry Goliath.

Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck

Merck's Zepatier poses a new challenge to Gilead's best-selling drug, but maybe it's not as threatening as some think.

1 Chart That's Bringing Big Smiles to America's Largest Companies

You might be witnessing a sea of red, but the recent retracement in this index could be a very good thing for America's largest companies.

See More MRK News...

MRK's Top Competitors

MRK $48.85 (-1.37%)
Current stock: MRK
JNJ $101.70 (-0.03%)
Current stock: JNJ
NVS $72.20 (-1.08%)
Current stock: NVS
PFE $29.13 (-1.22%)
Current stock: PFE